Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanping Xu

Showing results (291-300 of 305) with videos related to

Pageof 31
Sort By:
Annals of Translational Medicine|February 11, 2021
Deep learning for differentiating novel coronavirus pneumonia and influenza pneumoniaMin Zhou, Dexiang Yang, Yong Chen, et al.
Journal of the American Chemical Society|February 10, 2026
Unconventional-Phase 1T'-Transition Metal Dichalcogenide Monolayers Grown on Amorphous Templates for Highly Efficient Hydrogen EvolutionZijian Li, Hua Yang, Mingjun Sun, et al.
Emerging Microbes & Infections|February 11, 2020
Seroprevalence of AIH-related autoantibodies in patients with acute hepatitis E viral infection: a prospective case-control study in ChinaJian Wu, Naizhou Guo, Lifei Zhu, et al.
Scientific Reports|July 2, 2025
Molecular docking and biological evaluation of a novel IWS1 inhibitor for the treatment of human retroperitoneal liposarcomaMarina Goryunova, Yiran He, Carson Karakis, et al.
Journal of Medicinal Chemistry|July 19, 2021
Discovery of Highly Potent and Selective IRAK1 Degraders to Probe Scaffolding Functions of IRAK1 in ABC DLBCLLiqiang Fu, Jing Zhang, Bin Shen, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonistsQing Shi, Emily J Canada, Yanping Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2012
Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft modelsJingchuan Zhang, Lin Zhang, Xinying Su, et al.
Cell Chemical Biology|September 5, 2020
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein DegradationJing Zhang, Liqiang Fu, Bin Shen, et al.
Journal of Medicinal Chemistry|November 14, 2003
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonistYanping Xu, Daniel Mayhugh, Ashraf Saeed, et al.
Scientific Reports|November 17, 2020
VADER: a variable dose-rate external <sup>137</sup>Cs irradiator for internal emitter and low dose rate studiesGuy Garty, Yanping Xu, Gary W Johnson, et al.
Pageof 31

Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Annals of Translational Medicine|February 11, 2021
Deep learning for differentiating novel coronavirus pneumonia and influenza pneumoniaMin Zhou, Dexiang Yang, Yong Chen, et al.
Journal of the American Chemical Society|February 10, 2026
Unconventional-Phase 1T'-Transition Metal Dichalcogenide Monolayers Grown on Amorphous Templates for Highly Efficient Hydrogen EvolutionZijian Li, Hua Yang, Mingjun Sun, et al.
Emerging Microbes & Infections|February 11, 2020
Seroprevalence of AIH-related autoantibodies in patients with acute hepatitis E viral infection: a prospective case-control study in ChinaJian Wu, Naizhou Guo, Lifei Zhu, et al.
Scientific Reports|July 2, 2025
Molecular docking and biological evaluation of a novel IWS1 inhibitor for the treatment of human retroperitoneal liposarcomaMarina Goryunova, Yiran He, Carson Karakis, et al.
Journal of Medicinal Chemistry|July 19, 2021
Discovery of Highly Potent and Selective IRAK1 Degraders to Probe Scaffolding Functions of IRAK1 in ABC DLBCLLiqiang Fu, Jing Zhang, Bin Shen, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonistsQing Shi, Emily J Canada, Yanping Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2012
Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft modelsJingchuan Zhang, Lin Zhang, Xinying Su, et al.
Cell Chemical Biology|September 5, 2020
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein DegradationJing Zhang, Liqiang Fu, Bin Shen, et al.
Journal of Medicinal Chemistry|November 14, 2003
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonistYanping Xu, Daniel Mayhugh, Ashraf Saeed, et al.
Scientific Reports|November 17, 2020
VADER: a variable dose-rate external <sup>137</sup>Cs irradiator for internal emitter and low dose rate studiesGuy Garty, Yanping Xu, Gary W Johnson, et al.
Pageof 31